The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications?

被引:2
|
作者
Leko, Andras H. [1 ,2 ,3 ]
Ray, Lara A. [4 ,5 ]
Leggio, Lorenzo [1 ,2 ,6 ,7 ,8 ]
机构
[1] NIDA, Clin Psychoneuroendocrinol & Neuropsychopharmacol, Translat Addict Med Branch, Intramural Res Program,NIH, Bethesda, MD 20892 USA
[2] NIAAA, Div Intramural Clin & Biol Res, NIH, Bethesda, MD 20892 USA
[3] NIH, Ctr Compuls Behav, Intramural Res Program, Bethesda, MD USA
[4] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA
[5] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA
[6] Brown Univ, Ctr Alcohol & Addict Studies, Dept Behav & Social Sci, Providence, RI USA
[7] Johns Hopkins Univ, Sch Med, Dept Med, Div Addict Med, Baltimore, MD USA
[8] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC USA
来源
关键词
RECEPTOR; NEUROINFLAMMATION; EXPRESSION; DRINKING;
D O I
10.1111/acer.15049
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:843 / 847
页数:5
相关论文
共 50 条
  • [31] Expanding the Use of Medications for Alcohol Use Disorder: Lessons from the Proliferation of Anti-obesity Medications
    Bernstein, Eden Y.
    Moreno, Jorge O.
    Edelman, E. Jennifer
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (07) : 1233 - 1235
  • [32] The transition to parenthood, opportunity to drink, drinking, and alcohol use disorder
    Axinn, William G.
    Banchoff, Emma
    Cole, Faith
    Ghimire, Dirgha J.
    Smoller, Jordan W.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 241
  • [33] Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis
    Roberts, Sarah C. M.
    Liu, Guodong
    Terplan, Mishka
    JOURNAL OF ADDICTION MEDICINE, 2025, 19 (01) : 41 - 46
  • [34] Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder
    Haass-Koffler, Carolina L.
    Perciballi, Roberta
    ALCOHOL AND ALCOHOLISM, 2020, 55 (02): : 129 - 135
  • [35] Anti-craving medications for alcohol to treat moderate to severe alcohol use disorder
    Mong, Jon
    Ahamad, Keith
    Bach, Paxton
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (30) : E1196 - E1197
  • [36] PRESCRIPTION PATTERNS OF MEDICATIONS FOR ALCOHOL USE DISORDER IN PATIENTS WITH ALCOHOL-RELATED CIRRHOSIS
    Rabiee, Anahita
    Mahmud, Nadim
    Falker, Caroline
    Garcia-Tsao, Guadalupe
    Kaplan, David E.
    Taddei, Tamar H.
    HEPATOLOGY, 2022, 76 : S976 - S977
  • [37] Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development
    Litten, Raye Z.
    Falk, Daniel E.
    Ryan, Megan L.
    Fertig, Joanne B.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 (07) : 1368 - 1379
  • [38] Mining clinical data for novel medications to treat alcohol use disorder
    Rozema, Luke
    Hoyt, Jessica E.
    V. Watts, Bradley
    Shiner, Brian
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 163
  • [39] GABAERGIC MEDICATIONS IN THE TREATMENT OF ALCOHOL USE DISORDER: THEIR EVOLUTION IN EUROPEAN PRACTICE
    Addolorato, G.
    ALCOHOL AND ALCOHOLISM, 2014, 49
  • [40] Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge
    Bernstein, Eden Y.
    Baggett, Travis P.
    Trivedi, Shrunjal
    Herzig, Shoshana J.
    Anderson, Timothy S.
    JAMA NETWORK OPEN, 2024, 7 (03) : E243387